Press Releases

Date Title and Summary Additional Formats
Toggle Summary NewLink Genetics to Present Phase 2 Data of Its HyperAcute(R) Lung Immunotherapy at AACR 102nd Annual Meeting 2011
NewLink Genetics to Present Phase 2 Data of Its HyperAcute(R) Lung Immunotherapy at AACR 102nd Annual Meeting 2011 AMES, Iowa, April 1, 2011 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the Company's investigational
View HTML